These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28190252)

  • 1. The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.
    Thomas JS; Hanby AM; Russell N; van Tienhoven G; Riddle K; Anderson N; Cameron DA; Bartlett JM; Piper T; Cunningham C; Canney P; Kunkler IH;
    Breast Cancer Res Treat; 2017 May; 163(1):63-69. PubMed ID: 28190252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic concordance of reporting lymphovascular invasion in breast cancer.
    Rakha EA; Abbas A; Pinto Ahumada P; ElSayed ME; Colman D; Pinder SE; Ellis IO
    J Clin Pathol; 2018 Sep; 71(9):802-805. PubMed ID: 29599396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy.
    Lin PH; Yeh MH; Liu LC; Chen CJ; Tsui YC; Su CH; Wang HC; Liang JA; Chang HW; Wu HS; Yeh SP; Li LY; Chiu CF
    J Surg Oncol; 2013 Nov; 108(6):352-7. PubMed ID: 23996583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in breast cancer pathology practices among medicare patients undergoing unilateral extended simple mastectomy.
    Imperato PJ; Waisman J; Wallen MD; Llewellyn CC; Pryor V
    Am J Med Qual; 2003; 18(4):164-70. PubMed ID: 12934953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy.
    Truong PT; Lesperance M; Culhaci A; Kader HA; Speers CH; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):175-82. PubMed ID: 15850919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
    Boutrus R; Abi-Raad R; Niemierko A; Brachtel EF; Rizk L; Kelada A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):793-8. PubMed ID: 20171799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation.
    Jagsi R; Raad RA; Goldberg S; Sullivan T; Michaelson J; Powell SN; Taghian AG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1035-9. PubMed ID: 15990006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and completeness of pathology reporting--impact on partial breast irradiation eligibility.
    Pignol JP; Rakovitch E; Zeppieri J; Hanna W
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):177-82. PubMed ID: 21937204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical outcome of breast cancer patients with T1-2 tumor and one to three positive nodes with or without postmastectomy radiation therapy.
    Huang CJ; Hou MF; Chuang HY; Lian SL; Huang MY; Chen FM; Fu OY; Lin SF
    Jpn J Clin Oncol; 2012 Aug; 42(8):711-20. PubMed ID: 22645150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
    Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
    Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.
    Yang PS; Chen CM; Liu MC; Jian JM; Horng CF; Liu MJ; Yu BL; Lee MY; Chi CW
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):516-22. PubMed ID: 19577858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post mastectomy radiotherapy in breast cancer: a survey of current United Kingdom practice.
    Mallon PT; McIntosh SA
    J BUON; 2012; 17(2):245-8. PubMed ID: 22740200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger.
    Floyd SR; Buchholz TA; Haffty BG; Goldberg S; Niemierko A; Raad RA; Oswald MJ; Sullivan T; Strom EA; Powell SN; Katz A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):358-64. PubMed ID: 16887288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.